echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Small: Development of coordination-responsive biodegradable biomaterials

    Small: Development of coordination-responsive biodegradable biomaterials

    • Last Update: 2021-08-06
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Some chemotherapeutic drugs (doxorubicin, paclitaxel, oxaliplatin, etc.


    Mesoporous silica (mesoporous silicon) nanomaterials have the advantages of simple synthesis, controllable structure, good chemical tailoring and biocompatibility, and have good clinical application prospects


    Recently, Dong Wenfei, a researcher at the Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, collaborated with Shao Dan, a researcher at South China University of Technology, and Sun Wen, a professor at Dalian University of Technology, to build di-selenium bond bridged mesoporous silica materials (MONs) through coordination.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.